Pfizer Zeldox Prolongs QT Interval 30 To 60 Msec In 11.6% Of Patients
Executive Summary
The oral formulation of Pfizer's Zeldox is associated with a QT prolongation of 30 to 60 milliseconds in 11.6% of patients, an update of Swedish labeling for the atypical antipsychotic states.